Gemcitabine Market 2027 by Application, End-User, Distribution Channel and Geography | The Insight Partners

Gemcitabine Market Forecast to 2027 - Covid-19 Impact and Global Analysis - By Application ( Pancreas Cancer, Non-Small Cell Lung Cancer, Bladder Cancer, Soft-Tissue Sarcoma, Metastatic Breast Cancer, Ovarian Cancer ); End-User ( Hospitals, Cancer Centers, Others ); Distribution Channel ( Online Pharmacies, Retail Pharmacies, Hospital Pharmacies ) and Geography

Report Code: TIPRE00008995 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
Covid
MARKET INTRODUCTION

Gemcitabine is an anti-cancer ("antineoplastic" or "cytotoxic") chemotherapy drug. Gemcitabine belongs to the family of drugs called antimetabolites.

MARKET DYNAMICS

Rising prevalence of cancer globally is the major factor propelling the market growth. Moreover, Initiatives by key players, and the growing number of patient support organizations and governmental & healthcare agencies to spread awareness regarding cancer is projected to drive the global gemcitabine market. However, side effects associated with the drug may impede the market growth.

MARKET SCOPE
`
The "Global Gemcitabine Market analysis to 2027" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of Gemcitabine Market with detailed market segmentation by, application, end-use, distribution channel and geography. The Global Gemcitabine Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Gemcitabine Market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The Global Gemcitabine Market is segmented on the basis of application, end-use and distribution channel. On the basis of application, the Global Gemcitabine Market is categorized into pancreas cancer, non-small cell lung cancer, bladder cancer, soft-tissue sarcoma, metastatic breast cancer, ovarian cancer. Based on end-use, the market is segmented as hospitals, cancer centers, and others. Based on distribution channel the market is segmented into online pharmacies, retail pharmacies and hospital pharmacies.
?

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Gemcitabine Market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Gemcitabine Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Gemcitabine Market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trends. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Gemcitabine Market in these regions.



Get more information on this report :

MARKET PLAYERS

The report covers key developments in the Gemcitabine Market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Gemcitabine Market are anticipated to lucrative growth opportunities in the future with the rising demand for Gemcitabine Market in the global market. Below mentioned is the list of few companies engaged in the Gemcitabine Market.

The report also includes the profiles of key Gemcitabine Market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

- Teva Pharmaceutical Industries Ltd.
- Sanofi
- Biocon.
- Dr. Reddy's Laboratories
- Sun Pharmaceutical Industries Ltd.
- Mylan N.V.
- GlaxoSmithKline plc.
- AstraZeneca plc.

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Gemcitabine Market - By Application
1.3.2 Gemcitabine Market - By End-User
1.3.3 Gemcitabine Market - By Distribution Channel
1.3.4 Gemcitabine Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. GEMCITABINE MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. GEMCITABINE MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. GEMCITABINE MARKET - GLOBAL MARKET ANALYSIS
6.1. GEMCITABINE - GLOBAL MARKET OVERVIEW
6.2. GEMCITABINE - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. GEMCITABINE MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
7.1. OVERVIEW
7.2. APPLICATION MARKET FORECASTS AND ANALYSIS
7.3. PANCREAS CANCER
7.3.1. Overview
7.3.2. Pancreas Cancer Market Forecast and Analysis
7.4. NON-SMALL CELL LUNG CANCER
7.4.1. Overview
7.4.2. Non-Small Cell Lung Cancer Market Forecast and Analysis
7.5. BLADDER CANCER
7.5.1. Overview
7.5.2. Bladder Cancer Market Forecast and Analysis
7.6. SOFT-TISSUE SARCOMA
7.6.1. Overview
7.6.2. Soft-Tissue Sarcoma Market Forecast and Analysis
7.7. METASTATIC BREAST CANCER
7.7.1. Overview
7.7.2. Metastatic Breast Cancer Market Forecast and Analysis
7.8. OVARIAN CANCER
7.8.1. Overview
7.8.2. Ovarian Cancer Market Forecast and Analysis
8. GEMCITABINE MARKET - REVENUE AND FORECASTS TO 2027 - END-USER
8.1. OVERVIEW
8.2. END-USER MARKET FORECASTS AND ANALYSIS
8.3. HOSPITALS
8.3.1. Overview
8.3.2. Hospitals Market Forecast and Analysis
8.4. CANCER CENTERS
8.4.1. Overview
8.4.2. Cancer Centers Market Forecast and Analysis
8.5. OTHERS
8.5.1. Overview
8.5.2. Others Market Forecast and Analysis
9. GEMCITABINE MARKET - REVENUE AND FORECASTS TO 2027 - DISTRIBUTION CHANNEL
9.1. OVERVIEW
9.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
9.3. ONLINE PHARMACIES
9.3.1. Overview
9.3.2. Online Pharmacies Market Forecast and Analysis
9.4. RETAIL PHARMACIES
9.4.1. Overview
9.4.2. Retail Pharmacies Market Forecast and Analysis
9.5. HOSPITAL PHARMACIES
9.5.1. Overview
9.5.2. Hospital Pharmacies Market Forecast and Analysis
10. GEMCITABINE MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Gemcitabine Market Overview
10.1.2 North America Gemcitabine Market Forecasts and Analysis
10.1.3 North America Gemcitabine Market Forecasts and Analysis - By Application
10.1.4 North America Gemcitabine Market Forecasts and Analysis - By End-User
10.1.5 North America Gemcitabine Market Forecasts and Analysis - By Distribution Channel
10.1.6 North America Gemcitabine Market Forecasts and Analysis - By Countries
10.1.6.1 United States Gemcitabine Market
10.1.6.1.1 United States Gemcitabine Market by Application
10.1.6.1.2 United States Gemcitabine Market by End-User
10.1.6.1.3 United States Gemcitabine Market by Distribution Channel
10.1.6.2 Canada Gemcitabine Market
10.1.6.2.1 Canada Gemcitabine Market by Application
10.1.6.2.2 Canada Gemcitabine Market by End-User
10.1.6.2.3 Canada Gemcitabine Market by Distribution Channel
10.1.6.3 Mexico Gemcitabine Market
10.1.6.3.1 Mexico Gemcitabine Market by Application
10.1.6.3.2 Mexico Gemcitabine Market by End-User
10.1.6.3.3 Mexico Gemcitabine Market by Distribution Channel
10.2. EUROPE
10.2.1 Europe Gemcitabine Market Overview
10.2.2 Europe Gemcitabine Market Forecasts and Analysis
10.2.3 Europe Gemcitabine Market Forecasts and Analysis - By Application
10.2.4 Europe Gemcitabine Market Forecasts and Analysis - By End-User
10.2.5 Europe Gemcitabine Market Forecasts and Analysis - By Distribution Channel
10.2.6 Europe Gemcitabine Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Gemcitabine Market
10.2.6.1.1 Germany Gemcitabine Market by Application
10.2.6.1.2 Germany Gemcitabine Market by End-User
10.2.6.1.3 Germany Gemcitabine Market by Distribution Channel
10.2.6.2 France Gemcitabine Market
10.2.6.2.1 France Gemcitabine Market by Application
10.2.6.2.2 France Gemcitabine Market by End-User
10.2.6.2.3 France Gemcitabine Market by Distribution Channel
10.2.6.3 Italy Gemcitabine Market
10.2.6.3.1 Italy Gemcitabine Market by Application
10.2.6.3.2 Italy Gemcitabine Market by End-User
10.2.6.3.3 Italy Gemcitabine Market by Distribution Channel
10.2.6.4 Spain Gemcitabine Market
10.2.6.4.1 Spain Gemcitabine Market by Application
10.2.6.4.2 Spain Gemcitabine Market by End-User
10.2.6.4.3 Spain Gemcitabine Market by Distribution Channel
10.2.6.5 United Kingdom Gemcitabine Market
10.2.6.5.1 United Kingdom Gemcitabine Market by Application
10.2.6.5.2 United Kingdom Gemcitabine Market by End-User
10.2.6.5.3 United Kingdom Gemcitabine Market by Distribution Channel
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Gemcitabine Market Overview
10.3.2 Asia-Pacific Gemcitabine Market Forecasts and Analysis
10.3.3 Asia-Pacific Gemcitabine Market Forecasts and Analysis - By Application
10.3.4 Asia-Pacific Gemcitabine Market Forecasts and Analysis - By End-User
10.3.5 Asia-Pacific Gemcitabine Market Forecasts and Analysis - By Distribution Channel
10.3.6 Asia-Pacific Gemcitabine Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Gemcitabine Market
10.3.6.1.1 Australia Gemcitabine Market by Application
10.3.6.1.2 Australia Gemcitabine Market by End-User
10.3.6.1.3 Australia Gemcitabine Market by Distribution Channel
10.3.6.2 China Gemcitabine Market
10.3.6.2.1 China Gemcitabine Market by Application
10.3.6.2.2 China Gemcitabine Market by End-User
10.3.6.2.3 China Gemcitabine Market by Distribution Channel
10.3.6.3 India Gemcitabine Market
10.3.6.3.1 India Gemcitabine Market by Application
10.3.6.3.2 India Gemcitabine Market by End-User
10.3.6.3.3 India Gemcitabine Market by Distribution Channel
10.3.6.4 Japan Gemcitabine Market
10.3.6.4.1 Japan Gemcitabine Market by Application
10.3.6.4.2 Japan Gemcitabine Market by End-User
10.3.6.4.3 Japan Gemcitabine Market by Distribution Channel
10.3.6.5 South Korea Gemcitabine Market
10.3.6.5.1 South Korea Gemcitabine Market by Application
10.3.6.5.2 South Korea Gemcitabine Market by End-User
10.3.6.5.3 South Korea Gemcitabine Market by Distribution Channel
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Gemcitabine Market Overview
10.4.2 Middle East and Africa Gemcitabine Market Forecasts and Analysis
10.4.3 Middle East and Africa Gemcitabine Market Forecasts and Analysis - By Application
10.4.4 Middle East and Africa Gemcitabine Market Forecasts and Analysis - By End-User
10.4.5 Middle East and Africa Gemcitabine Market Forecasts and Analysis - By Distribution Channel
10.4.6 Middle East and Africa Gemcitabine Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Gemcitabine Market
10.4.6.1.1 South Africa Gemcitabine Market by Application
10.4.6.1.2 South Africa Gemcitabine Market by End-User
10.4.6.1.3 South Africa Gemcitabine Market by Distribution Channel
10.4.6.2 Saudi Arabia Gemcitabine Market
10.4.6.2.1 Saudi Arabia Gemcitabine Market by Application
10.4.6.2.2 Saudi Arabia Gemcitabine Market by End-User
10.4.6.2.3 Saudi Arabia Gemcitabine Market by Distribution Channel
10.4.6.3 U.A.E Gemcitabine Market
10.4.6.3.1 U.A.E Gemcitabine Market by Application
10.4.6.3.2 U.A.E Gemcitabine Market by End-User
10.4.6.3.3 U.A.E Gemcitabine Market by Distribution Channel
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Gemcitabine Market Overview
10.5.2 South and Central America Gemcitabine Market Forecasts and Analysis
10.5.3 South and Central America Gemcitabine Market Forecasts and Analysis - By Application
10.5.4 South and Central America Gemcitabine Market Forecasts and Analysis - By End-User
10.5.5 South and Central America Gemcitabine Market Forecasts and Analysis - By Distribution Channel
10.5.6 South and Central America Gemcitabine Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Gemcitabine Market
10.5.6.1.1 Brazil Gemcitabine Market by Application
10.5.6.1.2 Brazil Gemcitabine Market by End-User
10.5.6.1.3 Brazil Gemcitabine Market by Distribution Channel
10.5.6.2 Argentina Gemcitabine Market
10.5.6.2.1 Argentina Gemcitabine Market by Application
10.5.6.2.2 Argentina Gemcitabine Market by End-User
10.5.6.2.3 Argentina Gemcitabine Market by Distribution Channel
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. GEMCITABINE MARKET, KEY COMPANY PROFILES
12.1. TEVA PHARMACEUTICAL INDUSTRIES LTD.
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. SANOFI
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. BIOCON.
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. DR. REDDY’S LABORATORIES
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. SUN PHARMACEUTICAL INDUSTRIES LTD.
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. MYLAN N.V.
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. GLAXOSMITHKLINE PLC.
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. ASTRAZENECA PLC.
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. Teva Pharmaceutical Industries Ltd.
2. Sanofi
3. Biocon.
4. Dr. Reddy's Laboratories
5. Sun Pharmaceutical Industries Ltd.
6. Mylan N.V.
7. GlaxoSmithKline plc.
8. AstraZeneca plc.
TIPRE00008995
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking